Medical composition
A composition and coating technology, applied in the direction of drug combination, drug delivery, non-active ingredients of polymer compounds, etc., can solve problems affecting patient compliance and poor palatability
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0049] Cefuroxime axetil suspension 125mg / 5ml
[0050] Component 5mL dose %w / w
[0051] Cefuroxime axetil 0.150g 3.55
[0052] Stearic acid 0.852g 20.19
[0053] Povidone 0.013g 0.31
[0054] Tutti Frutti flavoring 0.100g 2.37
[0055] Sucrose 3.062g 72.56
[0056] Acesulfame Potassium 0.021g 0.50
[0057] Aspartame 0.021g 0.50
[0058] Xanthan gum 0.001g 0.02
[0059] Drinking water to 5mL
Embodiment 2
[0061] Cefuroxime axetil suspension 125mg / 5ml
[0062] Component 5mL dose %w / w
[0063] Cefuroxime axetil 0.150g 3.55
[0064] Stearic acid 0.852g 20.19
[0065] Povidone 0.013g 0.31
[0066] Tutti Frutti flavoring 0.100g 2.37
[0067] Sucrose 3.062g 72.56
[0068] Sodium saccharin 0.021g 0.50
[0069] Aspartame 0.021g 0.50
[0070] Xanthan gum 0.001g 0.02
[0071] Drinking water to 5mL
Embodiment 3
[0073] Cefuroxime axetil suspension 125mg / 5ml
[0074] Component 5mL dose %w / w
[0075] Cefuroxime axetil 0.150g 3.55
[0076] Stearic acid 0.852g 20.19
[0077] Povidone 0.013g 0.31
[0078] Tutti Frutti flavoring 0.100g 2.37
[0079] Sucrose 3.062g 72.56
[0080] Sodium saccharin 0.021g 0.50
[0081] Acesulfame Potassium 0.021g 0.50
[0082] Xanthan gum 0.001g 0.02
[0083] Drinking water to 5mL
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More